Maersk has entered a partnership with manufacturer Covaxx for the distribution of its COVID-19 vaccine — which is currently in phase 1 clinical trials — once it is approved by regulatory authorities, according to an announcement Monday from the logistics company. The agreement between the two companies lays out a plan for the end-to-end supply […]

COVAXX, a US company developing a synthetic multitope peptide-based vaccine to fight COVID-19, today announced a global logistics partnership with Maersk, one of the world’s largest shipping and integrated logistics providers.